Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Melanoma/Skin Cancer
•
Medical Oncology
What is your approach to treating inoperable mucosal melanoma of the head and neck region?
What is the preferred dose, fractionation, and role of concurrent chemo?
Answer from: Radiation Oncologist at Academic Institution
It is often nasal cavity/paranasal sinuses, so 1.2 Gy BID to 74.4 Gy and electively treat the neck. Otherwise 70 Gy/35 fx/30 treatment days SIB.
Comments
Radiation Oncologist at The Toledo Clinic
Do you treat only the ipsilateral neck?
Radiation Oncologist at University of Florida
I would treat the ipsilateral neck electively.
Radiation Oncologist at The Toledo Clinic
Thank you.
Radiation Oncologist at Providence St. Mary Medical Center
Role for immunotherapy? Neoadj or Adj?
10987
10991
10993
14435
Sign in or Register to read more
675
Related Questions
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
How would you treat locally advanced melanoma of the scalp with several in transit lesions and a metastatic lesion to the parotid if the patient is progressing on immunotherapy such as pembrolizumab?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
How, if at all, are you modifying your practice and clinical workflow for patients receiving checkpoint inhibitors with data showing improved outcomes for patients receiving infusions earlier in the day?
How would you apply the results of CheckMate 204 in an asymptomatic patient with 10-20 metastatic brain lesions on dual immunotherapy for melanoma?
When would you offer neoadjuvant immunotherapy prior to Mohs surgery in a locally advanced squamous cell carcinoma for which clearance may require enucleation?
Would you consider adjuvant immunotherapy for a patient with high-risk (N3 nodes) Merkel cell carcinoma following definitive surgical resection and adjuvant radiation therapy?
Do you treat only the ipsilateral neck?
I would treat the ipsilateral neck electively.
Thank you.
Role for immunotherapy? Neoadj or Adj?